Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients

High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT) is still a consolidation treatment choice for relapsed/refractory B-cell non-Hodgkin’s lymphoma (NHL) patients and some aggressive B-cell NHL as frontline therapy. Due to the shortage of carmustine, we switc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Tian, Chen, Li, Yueyang, Liu, Su, Chen, Zehui, Zhang, Yizhuo, Yu, Yong, Yang, Hongliang, Zhao, Haifeng, Zhao, Zhigang, Yuan, Tian, Wang, Yafei
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7895978/
https://ncbi.nlm.nih.gov/pubmed/33608570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-81944-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky